AUG 19, 2026 · PHASE 3 TRIAL
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
ClinicalTrials.gov
This is an active Phase 3 trial registration with no results posted; it describes a planned long-term extension study in a defined population but carries no efficacy or safety data yet.
Reported
Planned sample size650
Primary outcome measureNumber of Participants With Treatment Emerg…
Trial phasePhase 3